Why Shares of Novavax Rose 31% Last Month

Why Shares of Novavax Rose 31% Last Month

Novavax (NASDAQ: NVAX) had a busy month in April. Shares gained 30% according to S&P Global Market Intelligence. Early in the month, the stock began climbing after Johnson & Johnson's vaccine was temporarily halted.